#South Korea #Seongnam #Rejuran #PharmaResearch #VIVACY

PharmaResearch Partners with VIVACY

PharmaResearch, a leading company in regenerative medicine, announced a significant partnership with VIVACY, a prominent medical aesthetic firm based in France, to facilitate the distribution of its medical device, Rejuran, across Europe. This strategic collaboration is set to enhance PharmaResearch's presence in key European markets including the UK, Germany, and France.

Expanding Reach Across Europe

the partnership leverages VIVACY's robust commercial and marketing networks, aiming for accelerated market entry in 22 European countries. The agreement, valued at approximately €54.5 million over five years, targets several critical Western European countries like Italy and Spain. With the foundation laid for a strong distribution network, PharmaResearch anticipates commencing product distribution in major European nations this year, followed by a gradual rollout throughout the region.

Rejuran: A Unique Medical Device

According to PharmaResearch’s CEO, Jihoon Sohn, Rejuran is presently the only medical device based on polydeoxyribonucleotides (PN) that has received approval under the EU Medical Devices Regulation (MDR). Sohn expressed confidence that this partnership would significantly increase Rejuran's global visibility and bolster its standing as a leading skin-stimulating brand in the international aesthetic medicine market.

VIVACY: Strengthening Market Position

Bertrand, the CEO of VIVACY, remarked on the promising alignment of Rejuran's brand positioning, product quality, and established efficacy with VIVACY's scientific reputation and robust commercial capabilities. He believes this partnership with PharmaResearch not only enables the provision of top-tier polydeoxyribonucleotide technology to physicians but also exemplifies a substantial commitment to delivering advanced skin regeneration solutions to patients.

PharmaResearch Overview

PharmaResearch is at the forefront of biopharmaceutical innovations aimed at enhancing life quality through regenerative medicine. Their diverse portfolio encompasses pharmaceuticals, medical devices, cosmetics, and dietary supplements, all built upon proprietary ingredients protected by numerous patents. Headquartered in Gangneung-si, South Korea, PharmaResearch also maintains a subsidiary in Costa Mesa, California, further solidifying its global footprint.

For further insights into their products and initiatives, visit PharmaResearch.

About VIVACY

Established in 2007 and based in Paris, VIVACY is a pioneer in regenerative aesthetics, manufacturing high-end hyaluronic acid medical devices. Notable for its exclusive PN-Like technology, VIVACY is widely recognized for its STYLAGE® and DESIRIAL® dermal filler products, as well as a recent partnership with Burgeon Biotechnology for their NOVUMA® biostimulator. With a strong presence in over 85 countries, VIVACY's dedication to innovation and quality remains unmatched.

To learn more about VIVACY's offerings, please visit VIVACY.